The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Eisai; Lilly; MSD; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - Eisai; MSD
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Lilly; PharmaMar; Roche
Efficacy and safety of olaparib according to age in BRCA-1/2 mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2 (AGO-OVAR 2.23/ENGOT-Ov21) study.
 
Fabian Trillsch
Honoraria - AstraZeneca; Clovis Oncology; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Roche; Tesaro
Research Funding - AstraZeneca; GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Beyhan Ataseven
No Relationships to Disclose
 
Rebecca Asher
No Relationships to Disclose
 
Coraline Dubot
No Relationships to Disclose
 
Andrew R. Clamp
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Clovis Oncology
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Immunogen (Inst); Lilly (Inst); Millennium (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Richard T. Penson
Honoraria - Abbvie; AstraZeneca; Clovis Oncology; Eisai; Genentech/Roche; Janssen; Merck; Newlink Genetics; Sutter Medical Group; Tesaro; Vascular Biogenics
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Eisai; Janssen; Merck; Newlink Genetics; Roche/Genentech; Sutter Medical Group; Tesaro; Vascular Biogenics
Research Funding - Array BioPharma; AstraZeneca; Eisai; Genentech; Merck; Regeneron; Sanofi; Tesaro; Vascular Biogenics
Patents, Royalties, Other Intellectual Property - Blackwell Publishing Medicine at a glance; BMJ; UpToDate
Travel, Accommodations, Expenses - AstraZeneca; Vascular Biogenics
Other Relationship - Abbvie; AstraZeneca
(OPTIONAL) Uncompensated Relationships - Care4ward
 
Amit M. Oza
Honoraria - Intas
Consulting or Advisory Role - Immunogen; Merck KGaA
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Amnon Amit
No Relationships to Disclose
 
Tomasz Huzarski
No Relationships to Disclose
 
Antonio Casado
No Relationships to Disclose
 
Giovanni Scambia
Speakers' Bureau - Clovis Oncology; MSD
 
Michael Friedlander
Honoraria - AstraZeneca; Lilly; MSD; Novartis; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Lilly; MSD; Novartis; Takeda
Speakers' Bureau - ACT Genomics; AstraZeneca
Research Funding - AstraZeneca (Inst); BeiGene (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
Keiichi Fujiwara
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Daiichi Sankyo; Kyowa Hakko Kirin; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Zeria Pharmaceutical
Consulting or Advisory Role - Eisai; MSD; Pfizer
Research Funding - AstraZeneca (Inst); Eisai (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Gabe S. Sonke
Consulting or Advisory Role - Novartis (Inst)
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
 
Hannelore denys
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Teva (Inst)
 
Elizabeth S. Lowe
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Eric Pujade-Lauraine
Honoraria - AstraZeneca; GlaxoSmithKline; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Incyte; Merck; Pfizer/EMD Serono; Roche; TESARO
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
Other Relationship - Arcagy-Gineco